NCT02227264View on ClinicalTrials.gov

Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Primary Hyperparathyroidism

Interventions

DRUG

Cinacalcet

Cinacalcet, Mimpara® 30mgx1-2 for 4 weeks

PROCEDURE

parathyroid adenomectomy

surgical removal of pathologic parathyroid tissue

Trial Locations (1)

171 76

Karolinska University Hospital, Stockholm

All Listed Sponsors

collaborator

Karolinska Institutet

OTHER

lead

Karolinska University Hospital

OTHER

NCT02227264 - Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? | Biotech Hunter | Biotech Hunter